The UK Spine is a national network of research and clinical collaborators focused on developing new medicines to support healthy ageing and includes Oxford, Birmingham, Dundee, the Crick and the Medicines Discovery Catapult. In alignment with the UK Life Sciences Industrial Strategy the UK Spine will contribute to developing the UK as a global hub for clinical research and medical innovation through efficient and effective partnerships between academia, industry and the charitable sectors.
Harpal will participate in a discussion panel on Day 2 of the meeting, for the session – ‘Infrastructure building for affordable medicines’. With advances in science and the understanding of disease, this panel will explore the development of novel clinical trial methodologies, new approval routes and adaptation of regulations by engaging experts in this field including policy makers and statutory bodies. The panel will also highlight the elements of the complex health and socio-economic components of the medicines discovery ecosystem with a view to identifying new financial models
For more information on the timing and attendance opportunities at the conference, contact Dr. Harpal Dillon Email: harpal.dhillon@hcdeconomics.com